Sale!

Oncomine Comprehensive Assay Test Cost

Original price was: 15,260 د.إ.Current price is: 13,740 د.إ.

-10%

The Oncomine Comprehensive Assay Test, available at DNA Labs UAE for a cost of 13,740 AED, is a cutting-edge, next-generation sequencing (NGS) test designed to detect genetic mutations and alterations in cancer patients. This comprehensive assay is capable of analyzing both DNA and RNA from solid tumors to identify a wide array of genetic variants across multiple cancer types. By pinpointing specific mutations, the Oncomine Comprehensive Assay aids oncologists in making informed decisions about personalized treatment options, including targeted therapies and clinical trial eligibility. Conducted in a state-of-the-art facility, DNA Labs UAE ensures precise and reliable results, supporting the advancement of precision medicine in cancer care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Oncomine Comprehensive Assay Test

Cost: AED 13,740.0

Test Name: Oncomine Comprehensive Assay Test

Components: Paraffin embedded tissue blocks

Sample Condition: Tumor tissue

Report Delivery: 2-3 weeks

Method: Next-Generation Sequencing (NGS)

Test Type: Genetics

Doctor: General Physician

Test Department: DNA Labs UAE

Pre Test Information

The Oncomine Comprehensive Assay Test requires a doctor’s prescription. However, it is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.

Test Details

The Oncomine Comprehensive Assay Test is a next-generation sequencing (NGS) panel designed to detect genetic alterations in cancer. It covers over 500 genes and can identify mutations, copy number variations, and gene fusions. The assay is compatible with various sample types, including formalin-fixed paraffin-embedded (FFPE) tissue, fresh frozen tissue, and liquid biopsy samples. Please note that the Oncomine Comprehensive Assay Test is currently intended for clinical research purposes and is not approved for diagnostic use.

Running on the Ion Torrent sequencing platform, the assay utilizes semiconductor sequencing technology known for its speed and accuracy. This platform is ideal for NGS-based assays.

The Oncomine Comprehensive Assay Test provides researchers with a comprehensive view of the genomic landscape of a tumor, enabling a more personalized approach to cancer treatment. As research progresses on the genetic basis of cancer, assays like this one will play an increasingly vital role in the development of personalized cancer treatments.

Test Name Oncomine Comprehensive Assay Test
Components Paraffin embedded tissue blocks
Price 13740.0 AED
Sample Condition Tumor tissue
Report Delivery 2-3 weeks
Method NGS
Test type Genetics
Doctor General Physician
Test Department:
Pre Test Information Oncomine Comprehensive Assay can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

The Oncomine Comprehensive Assay is a next-generation sequencing (NGS) panel that is designed to detect genetic alterations in cancer. The panel covers over 500 genes and can identify mutations, copy number variations, and gene fusions. The assay is designed to work with a variety of sample types, including formalin-fixed paraffin-embedded (FFPE) tissue, fresh frozen tissue, and liquid biopsy samples.

The Oncomine Comprehensive Assay is intended for use in clinical research and is not currently approved for diagnostic use. It is designed to provide researchers with a comprehensive view of the genomic landscape of a tumor, allowing for a more personalized approach to cancer treatment.

The assay is run on the Ion Torrent sequencing platform, which uses semiconductor sequencing technology to detect genetic alterations. The platform is known for its speed and accuracy, making it an ideal choice for NGS-based assays.

Overall, the Oncomine Comprehensive Assay is a powerful tool for cancer research, providing researchers with a comprehensive view of the genomic alterations in a tumor. As more research is done on the genetic basis of cancer, assays like this one will become increasingly important for developing personalized cancer treatments.